Cargando…
Immunglobulin-A-Vaskulitis (IgAV)
IgA vasculitis (IgAV) is an immune complex-mediated vasculitis characterized by IgA1-dominant immune deposits in small vessels. It is the most common systemic vasculitis in childhood with a mostly uncomplicated and self-limiting course. Adults are less affected but the course is frequently more comp...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236391/ https://www.ncbi.nlm.nih.gov/pubmed/37266676 http://dx.doi.org/10.1007/s00393-023-01355-0 |
_version_ | 1785052908831637504 |
---|---|
author | Rose, Katharina Turner, Jan-Eric Iking-Konert, Christof |
author_facet | Rose, Katharina Turner, Jan-Eric Iking-Konert, Christof |
author_sort | Rose, Katharina |
collection | PubMed |
description | IgA vasculitis (IgAV) is an immune complex-mediated vasculitis characterized by IgA1-dominant immune deposits in small vessels. It is the most common systemic vasculitis in childhood with a mostly uncomplicated and self-limiting course. Adults are less affected but the course is frequently more complicated and more frequently accompanied by renal involvement. IgAV characteristically manifests itself on the skin with palpable purpura and in joints, the kidneys and the gastrointestinal tract. In cases of incomplete or atypical symptoms a differential diagnostic work-up is required. A number of triggers have been suggested, especially infections and drugs. Disease management is tailored to organ manifestations and the severity of the symptoms. For children, optimized supportive care and targeted symptom relief are usually sufficient. Management of renal and gastrointestinal manifestations follows recommendations for ANCA-associated vasculitis and IgA nephropathy. Treatment options include glucocorticoids and immunosuppressive agents with varying and mostly insufficient evidence. |
format | Online Article Text |
id | pubmed-10236391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-102363912023-06-06 Immunglobulin-A-Vaskulitis (IgAV) Rose, Katharina Turner, Jan-Eric Iking-Konert, Christof Z Rheumatol CME IgA vasculitis (IgAV) is an immune complex-mediated vasculitis characterized by IgA1-dominant immune deposits in small vessels. It is the most common systemic vasculitis in childhood with a mostly uncomplicated and self-limiting course. Adults are less affected but the course is frequently more complicated and more frequently accompanied by renal involvement. IgAV characteristically manifests itself on the skin with palpable purpura and in joints, the kidneys and the gastrointestinal tract. In cases of incomplete or atypical symptoms a differential diagnostic work-up is required. A number of triggers have been suggested, especially infections and drugs. Disease management is tailored to organ manifestations and the severity of the symptoms. For children, optimized supportive care and targeted symptom relief are usually sufficient. Management of renal and gastrointestinal manifestations follows recommendations for ANCA-associated vasculitis and IgA nephropathy. Treatment options include glucocorticoids and immunosuppressive agents with varying and mostly insufficient evidence. Springer Medizin 2023-06-02 /pmc/articles/PMC10236391/ /pubmed/37266676 http://dx.doi.org/10.1007/s00393-023-01355-0 Text en © The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | CME Rose, Katharina Turner, Jan-Eric Iking-Konert, Christof Immunglobulin-A-Vaskulitis (IgAV) |
title | Immunglobulin-A-Vaskulitis (IgAV) |
title_full | Immunglobulin-A-Vaskulitis (IgAV) |
title_fullStr | Immunglobulin-A-Vaskulitis (IgAV) |
title_full_unstemmed | Immunglobulin-A-Vaskulitis (IgAV) |
title_short | Immunglobulin-A-Vaskulitis (IgAV) |
title_sort | immunglobulin-a-vaskulitis (igav) |
topic | CME |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236391/ https://www.ncbi.nlm.nih.gov/pubmed/37266676 http://dx.doi.org/10.1007/s00393-023-01355-0 |
work_keys_str_mv | AT rosekatharina immunglobulinavaskulitisigav AT turnerjaneric immunglobulinavaskulitisigav AT ikingkonertchristof immunglobulinavaskulitisigav |